AstraZeneca

Data From 3 Roxadustat Trials Lead Off Kidney Week Sessions Ahead of Efficacy, Safety News
Data From 3 Roxadustat Trials Lead Off Kidney Week Sessions Ahead of Efficacy, Safety News
Managed Markets Network
nephrology
roxadustat
AstraZeneca
FibroGen
kidney disease
Flag link:
Top execs from AstraZeneca, Roche, Sanofi and GSK tout China investments at import expo
Top execs from AstraZeneca, Roche, Sanofi and GSK tout China investments at import expo
Fierce Pharma
China
AstraZeneca
Roche
Sanofi
GSK
Flag link:
AstraZeneca creates $1B Chinese fund, vows to double R&D team
AstraZeneca creates $1B Chinese fund, vows to double R&D team
Fierce Biotech
AstraZeneca
China
R&D
Flag link:
Daiichi Sankyo takes Seattle Genetics to court as battle over breast cancer drug escalates
Daiichi Sankyo takes Seattle Genetics to court as battle over breast cancer drug escalates
Pharmaforum
Daiichi Sankyo
Seattle Genetics
breast cancer
AstraZeneca
trastuzumab deruxtecan
Herceptin
Flag link:
Daiichi sues Seattle Genetics over tech used in high-profile ADC
Daiichi sues Seattle Genetics over tech used in high-profile ADC
Fierce Biotech
Daiichi Sankyo
Seattle Genetics
antibody-drug conjugate
AstraZeneca
DS-8201
Flag link:
AstraZeneca tops first Pharmaceutical Invention Index
AstraZeneca tops first Pharmaceutical Invention Index
Pharma Letter
AstraZeneca
R&D
Flag link:
Is AbbVie's Imbruvica concerned about AZ's rising Calquence? We've got this covered, execs say
Is AbbVie's Imbruvica concerned about AZ's rising Calquence? We've got this covered, execs say
Fierce Pharma
AbbVie
Rinvoq
AstraZeneca
Calquence
Imbruvica
Flag link:
AstraZeneca to sell anti-psychotic medicine rights in Europe and Russia for $239m
AstraZeneca to sell anti-psychotic medicine rights in Europe and Russia for $239m
Pharmaceutical Business Review
AstraZeneca
Seroquel
antipsychotic
Europe
Russia
Cheplapharm
Flag link:
AstraZeneca, on BMS' heels, scores lung cancer win with Imfinzi combos
AstraZeneca, on BMS' heels, scores lung cancer win with Imfinzi combos
Fierce Pharma
AstraZeneca
Imfinizi
non-small cell lung cancer
Flag link:
AstraZeneca Beats Expectations, China Momentum Continues — Earnings Review
AstraZeneca Beats Expectations, China Momentum Continues — Earnings Review
Morningstar
AstraZeneca
earnings
Flag link:
AstraZeneca dumps phase 3 renal cell carcinoma program
AstraZeneca dumps phase 3 renal cell carcinoma program
Fierce Biotech
AstraZeneca
savolitinib
renal cell carcinoma
Flag link:
What's in the Cards for AstraZeneca (AZN) in Q3 Earnings?
What's in the Cards for AstraZeneca (AZN) in Q3 Earnings?
Yahoo/Zacks.com
earnings
AstraZeneca
Flag link:
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
Endpoints
AstraZeneca
Farxiga
type 1 diabetes
heart failure
Flag link:
A change of the guard for the world’s biggest cancer companies
A change of the guard for the world’s biggest cancer companies
EP Vantage
cancer
Bristol-Myers Squibb
Celgene
M&A
Roche
AstraZeneca
Flag link:
AstraZeneca gets Q2 2020 PDUFA date for breast cancer ADC
AstraZeneca gets Q2 2020 PDUFA date for breast cancer ADC
Fierce Biotech
AstraZeneca
FDA
antibody-drug conjugate
trastuzumab deruxtecan
breast cancer
Flag link:
MedImmune's top cancer researcher jumps ship to small biotech
MedImmune's top cancer researcher jumps ship to small biotech
Fierce Biotech
R&D
MedImmune
AstraZeneca
Pyxis Oncology
Flag link:
AZ got past FluMist's efficacy woes, but now it's plagued by production problems
AZ got past FluMist's efficacy woes, but now it's plagued by production problems
Fierce Pharma
AstraZeneca
FluMist
Flag link:
ImaginAb joins with AZ, Pfizer and Takeda to develop tumour imaging tech
ImaginAb joins with AZ, Pfizer and Takeda to develop tumour imaging tech
Pharmaforum
ImaginAb
tumor imaging
AstraZeneca
Pfizer
Takeda
Flag link:
Big Pharma giving more money to patient advocacy groups
Big Pharma giving more money to patient advocacy groups
Beckers Hospital Review
Big Pharma
JNJ
AbbVie
Bristol-Myers Squibb
Pfizer
Merck
AstraZeneca
patient advocacy groups
Flag link:
Lilly touts Cyramza lung cancer data, as AZ’s Tagrisso grows even more powerful
Lilly touts Cyramza lung cancer data, as AZ’s Tagrisso grows even more powerful
Fierce Pharma
EGFR lung cancer
lung cancer
Eli Lilly
Cyramza
AstraZeneca
Tagrisso
Flag link:

Pages